In the dosing conditions trial, eligible subjects were healthy men, aged 1855 years with a BMI of 18.530.0 kg/m 2
GeroScience 42, 17511764
While GLP-1 medications have gained attention for weight management, food manufacturers are responding by developing products that provide greater satiety, protein, fibre, and overall nutritional value
Dopamine (00:25:33) Tool: Managing Interruptions (00:25:29) Sponsor: ROKA (00:26:57) Sit or Stand for Work?, Tool: Sit-Stand Desk (00:30:45) Key Takeaways, Flexibility & Changing Locations Disclaimer & Disclosures Learn more about your ad choices
Research suggests it may support significant weight loss while also improving blood sugar control, insulin sensitivity, and other metabolic markers, which is why it is being closely watched as a potential dual-purpose therapy
Take as recommended by your doctor